Engineering of versatile redox partner fusions that support monooxygenase activity of functionally diverse cytochrome P450s

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Bakkes, Patrick J ^a   Riehm, Jan L ^b   Sagadin, Tanja ^b   Rühlmann, Ansgar ^a   Schubert, Peter ^a   Biemann, Stefan ^a   Girhard, Marco ^a   Hutter, Michael C ^b   Bernhardt, Rita ^b   Urlacher, Vlada B ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CYTOCHROME P450; FUSION PROTEIN; MIXED FUNCTION OXIDASE;

BACILLUS SUBTILIS; CATALYSIS; ENZYME ACTIVATION; ESCHERICHIA COLI; GENETICS; METABOLISM; OXIDATION REDUCTION REACTION; PROTEIN ENGINEERING;

BACILLUS SUBTILIS; BACTERIAL PROTEINS; CATALYSIS; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME ACTIVATION; ESCHERICHIA COLI; MIXED FUNCTION OXYGENASES; OXIDATION-REDUCTION; PROTEIN ENGINEERING; RECOMBINANT FUSION PROTEINS;

EID: 85028474494     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-10075-w     Document Type: Article

References (76)

1. Lamb, D. C. & Waterman, M. R. Unusual properties of the cytochrome P450 superfamily. Philos. Trans. R. Soc. Lond. B Biol. Sci. 368, 20120434, doi:10.1098/rstb.2012.0434 (2013).
2. Girvan, H. M. & Munro, A. W. Applications of microbial cytochrome P450 enzymes in biotechnology and synthetic biology. Curr. Opin. Chem. Biol. 31, 136-145, doi:10.1016/j.cbpa.2016.02.018 (2016).
3. Whitehouse, C. J., Bell, S. G. & Wong, L. L. P450(BM3) (CYP102A1): connecting the dots. Chem. Soc. Rev. 41, 1218-1260, doi:10.1039/c1cs15192d (2012).
4. Podust, L. M. & Sherman, D. H. Diversity of P450 enzymes in the biosynthesis of natural products. Nat. Prod. Rep. 29, 1251-1266, doi:10.1039/c2np20020a (2012).
5. Bernhardt, R. Cytochromes P450 as versatile biocatalysts. J. Biotechnol. 124, 128-145, doi:10.1016/j.jbiotec.2006.01.026 (2006).
6. Behrendorff, J. B. & Gillam, E. M. Prospects for Applying Synthetic Biology to Toxicology: Future Opportunities and Current Limitations for the Repurposing of Cytochrome P450 Systems. Chem. Res. Toxicol. 30, 453-468, doi:10.1021/acs.chemrestox.6b00396 (2017).
7. Denisov, I. G., Makris, T. M., Sligar, S. G. & Schlichting, I. Structure and chemistry of cytochrome P450. Chem. Rev. 105, 2253-2277 (2005).
8. Hannemann, F., Bichet, A., Ewen, K. M. & Bernhardt, R. Cytochrome P450 systems - biological variations of electron transport chains. Biochim. Biophys. Acta 1770, 330-344 (2007).
9. McLean, K. J., Luciakova, D., Belcher, J., Tee, K. L. & Munro, A. W. Biological diversity of cytochrome P450 redox partner systems. Adv. Exp. Med. Biol. 851, 299-317, doi:10.1007/978-3-319-16009-2-11 (2015).
10. Urlacher, V. B. & Girhard, M. Cytochrome P450 monooxygenases: an update on perspectives for synthetic application. Trends Biotechnol. 30, 26-36, doi:10.1016/j.tibtech.2011.06.012 (2012).
11. Hlavica, P. Assembly of non-natural electron transfer conduits in the cytochrome P450 system: a critical assessment and update of artificial redox constructs amenable to exploitation in biotechnological areas. Biotechnol. Adv. 27, 103-121 (2009).
12. Girhard, M. et al. Regioselective biooxidation of (+)-valencene by recombinant E. coli expressing CYP109B1 from Bacillus subtilis in a two-liquid-phase system. Microb. Cell Fact. 8, 36 (2009).
13. Duan, Y. et al. Semi-rational engineering of cytochrome CYP153A from Marinobacter aquaeolei for improved omega-hydroxylation activity towards oleic acid. Appl. Microbiol. Biotechnol. doi:10.1007/s00253-016-7634-1 (2016).
14. Ewen, K. M., Ringle, M. & Bernhardt, R. Adrenodoxin-a versatile ferredoxin. IUBMB Life 64, 506-512, doi:10.1002/iub.1029 (2012).
15. Khatri, Y. et al. Regioselective hydroxylation of norisoprenoids by CYP109D1 from Sorangium cellulosum So ce56. Appl. Microbiol. Biotechnol. 88, 485-495, doi:10.1007/s00253-010-2756-3 (2010).
16. Girhard, M., Klaus, T., Khatri, Y., Bernhardt, R. & Urlacher, V. B. Characterization of the versatile monooxygenase CYP109B1 from Bacillus subtilis. Appl. Microbiol. Biotechnol. 87, 595-607, doi:10.1007/s00253-010-2472-z (2010).
17. von Bühler, C., Le-Huu, P. & Urlacher, V. B. Cluster screening: an effective approach for probing the substrate space of uncharacterized cytochrome P450s. Chem Bio Chem 14, 2189-2198, doi:10.1002/cbic.201300271 (2013).
18. Cao, P. R., Bulow, H., Dumas, B. & Bernhardt, R. Construction and characterization of a catalytic fusion protein system: P-450(11beta)-adrenodoxin reductase-adrenodoxin. Biochim. Biophys. Acta 1476, 253-264, doi:S0167-4838(99)00243-5 (2000).
19. Bakkes, P. J. et al. Design and improvement of artificial redox modules by molecular fusion of flavodoxin and flavodoxin reductase from Escherichia coli. Sci. Rep. 5, 12158, doi:10.1038/srep12158 (2015).
20. Sadeghi, S. J. & Gilardi, G. Chimeric P450 enzymes: activity of artificial redox fusions driven by different reductases for biotechnological applications. Biotechnol. Appl. Biochem. 60, 102-110 (2013).
21. Hirakawa, H., Kamiya, N., Tanaka, T. & Nagamune, T. Intramolecular electron transfer in a cytochrome P450cam system with a site-specific branched structure. Protein Eng. Des. Sel. 20, 453-459 (2007).
22. Sadeghi, S. J., Meharenna, Y. T., Fantuzzi, A., Valetti, F. & Gilardi, G. Engineering artificial redox chains by molecular 'Lego'. Faraday Discuss. 135-153(discussion), 171-190 (2000).
23. Li, S., Podust, L. M. & Sherman, D. H. Engineering and analysis of a self-sufficient biosynthetic cytochrome P450 PikC fused to the RhFRED reductase domain. J. Am. Chem. Soc. 129, 12940-12941, doi:10.1021/ja075842d (2007).
24. Li, S. et al. Selective oxidation of carbolide C-H bonds by an engineered macrolide P450 mono-oxygenase. Proc. Natl. Acad. Sci. USA. 106, 18463-18468, doi:10.1073/pnas.0907203106 (2009).
25. Shibata, M., Sakaki, T., Yabusaki, Y., Murakami, H. & Ohkawa, H. Genetically engineered P450 monooxygenases: construction of bovine P450c17/yeast reductase fused enzymes. DNA Cell Biol. 9, 27-36 (1990).
26. McLean, K. J., Girvan, H. M. & Munro, A. W. Cytochrome P450/redox partner fusion enzymes: biotechnological and toxicological prospects. Expert Opin. Drug Metab. Toxicol. 3, 847-863, doi:10.1517/17425255.3.6.847 (2007).
27. Lawson, R. J., von Wachenfeldt, C., Haq, I., Perkins, J. & Munro, A. W. Expression and characterization of the two flavodoxin proteins of Bacillus subtilis, YkuN and YkuP: biophysical properties and interactions with cytochrome P450 BioI. Biochemistry 43, 12390-12409 (2004).
28. Purdy, M. M., Koo, L. S., Ortiz de Montellano, P. R. & Klinman, J. P. Steady-state kinetic investigation of cytochrome P450cam: interaction with redox partners and reaction with molecular oxygen. Biochemistry 43, 271-281 (2004).
29. Jenkins, C. M. & Waterman, M. R. NADPH-flavodoxin reductase and flavodoxin from Escherichia coli: characteristics as a soluble microsomal P450 reductase. Biochemistry 37, 6106-6113 (1998).
30. + reductase revealed by protein engineering and crystallographic studies. Nat. Struct. Biol. 6, 847-853, doi:10.1038/12307 (1999).
31. Piubelli, L. et al. Competition between C-terminal tyrosine and nicotinamide modulates pyridine nucleotide affinity and specificity in plant ferredoxin-NADP(+) reductase. J. Biol. Chem. 275, 10472-10476 (2000).
32. Nogues, I. et al. Role of the C-terminal tyrosine of ferredoxin-nicotinamide adenine dinucleotide phosphate reductase in the electron transfer processes with its protein partners ferredoxin and flavodoxin. Biochemistry 43, 6127-6137, doi:10.1021/bi049858h (2004).
33. Moser, C. C., Keske, J. M., Warncke, K., Farid, R. S. & Dutton, P. L. Nature of biological electron transfer. Nature 355, 796-802, doi:10.1038/355796a0 (1992).
34. Omura, T. & Sato, R. The Carbon Monoxide-Binding Pigment of Liver Microsomes. I. Evidence for Its Hemoprotein Nature. J. Biol. Chem. 239, 2370-2378 (1964).
35. Girhard, M., Tieves, F., Weber, E., Smit, M. S. & Urlacher, V. B. Cytochrome P450 reductase from Candida apicola: versatile redox partner for bacterial P450s. Appl. Microbiol. Biotechnol. 97, 1625-1635, doi:10.1007/s00253-012-4026-z (2013).
36. Bogazkaya, A. M. et al. Selective allylic hydroxylation of acyclic terpenoids by CYP154E1 from Thermobifida fusca YX. Beilstein J. Org. Chem. 10, 1347-1353, doi:10.3762/bjoc.10.137 (2014).
37. Brenna, E., Fuganti, C., Serra, S. & Kraft, P. Optically active ionones and derivatives: Preparation and olfactory properties. Eur. J. Org. Chem., 967-978 (2002).
38. Lalko, J. et al. Fragrance material review on beta-ionone. Food Chem. Toxicol. 45(Suppl 1), S241-247, doi:10.1016/j.fct.2007.09.052 (2007).
39. Kakeya, H., Sugai, T. & Ohta, H. Biochemical preparation of optically active 4-hydroxy-ionone and its transformation to (S)-6-hydoxy-α-ionone. Agric. Biol. Chem. 55, 1873-1876 (1991).
40. Eschenmoser, W., Uebelhart, P. & Eugster, C. H. Synthesis and Chirality of the Enantiomeric 6-Hydroxy-Alpha-Ionones and of Cis and Trans-5,6-Dihydroxy-5,6-Dihydro-Beta-Ionones. Helv. Chim. Acta 64, 2681-2690 (1981).
41. Urlacher, V. B., Makhsumkhanov, A. & Schmid, R. D. Biotransformation of beta-ionone by engineered cytochrome P450 BM-3. Appl. Microbiol. Biotechnol. 70, 53-59 (2006).
42. Berg, A., Gustafsson, J. A. & Ingelman-Sundberg, M. Characterization of a cytochrome P-450-dependent steroid hydroxylase system present in Bacillus megaterium. J. Biol. Chem. 251, 2831-2838 (1976).
43. Lisurek, M., Simgen, B., Antes, I. & Bernhardt, R. Theoretical and experimental evaluation of a CYP106A2 low homology model and production of mutants with changed activity and selectivity of hydroxylation. Chem Bio Chem 9, 1439-1449, doi:10.1002/cbic.200700670 (2008).
44. Schmitz, D., Zapp, J. & Bernhardt, R. Steroid conversion with CYP106A2 - production of pharmaceutically interesting DHEA metabolites. Microb. Cell Fact. 13, 81, doi:10.1186/1475-2859-13-81 (2014).
45. Bleif, S. et al. A new Bacillus megaterium whole-cell catalyst for the hydroxylation of the pentacyclic triterpene 11-keto-betaboswellic acid (KBA) based on a recombinant cytochrome P450 system. Appl. Microbiol. Biotechnol. 93, 1135-1146, doi:10.1007/s00253-011-3467-0 (2012).
46. White, P. C., Tusie-Luna, M. T., New, M. I. & Speiser, P. W. Mutations in steroid 21-hydroxylase (CYP21). Hum. Mutat. 3, 373-378, doi:10.1002/humu.1380030408 (1994).
47. Brixius-Anderko, S., Schiffer, L., Hannemann, F., Janocha, B. & Bernhardt, R. A CYP21A2 based whole-cell system in Escherichia coli for the biotechnological production of premedrol. Microb. Cell Fact. 14, 135, doi:10.1186/s12934-015-0333-2 (2015).
48. Blaschkowski, H. P., Neuer, G., Ludwig-Festl, M. & Knappe, J. Routes of flavodoxin and ferredoxin reduction in Escherichia coli. CoA-acylating pyruvate: flavodoxin and NADPH: flavodoxin oxidoreductases participating in the activation of pyruvate formatelyase. Eur. J. Biochem. 123, 563-569 (1982).
49. Bianchi, V. et al. Flavodoxin is required for the activation of the anaerobic ribonucleotide reductase. Biochem. Biophys. Res. Commun. 197, 792-797, doi:10.1006/bbrc.1993.2548 (1993).
50. Razquin, P. et al. Differential activities of heterocyst ferredoxin, vegetative cell ferredoxin, and flavodoxin as electron carriers in nitrogen fixation and photosynthesis in Anabaena sp. Photosynth. Res. 43, 35-40, doi:10.1007/BF00029460 (1995).
51. Nieva-Gomez, D., Roberts, G. P., Klevickis, S. & Brill, W. J. Electron transport to nitrogenase in Klebsiella pneumoniae. Proc. Natl. Acad. Sci. U. S. A. 77, 2555-2558 (1980).
52. Fujii, K. & Huennekens, F. M. Activation of methionine synthetase by a reduced triphosphopyridine nucleotide-dependent flavoprotein system. J. Biol. Chem. 249, 6745-6753 (1974).
53. Birch, O. M., Fuhrmann, M. & Shaw, N. M. Biotin synthase from Escherichia coli, an investigation of the low molecular weight and protein components required for activity in vitro. J. Biol. Chem. 270, 19158-19165 (1995).
54. Dong, M. S., Yamazaki, H., Guo, Z. & Guengerich, F. P. Recombinant human cytochrome P450 1A2 and an N-terminal-truncated form: construction, purification, aggregation properties, and interactions with flavodoxin, ferredoxin, and NADPH-cytochrome P450 reductase. Arch. Biochem. Biophys. 327, 11-19, doi:10.1006/abbi.1996.0086 (1996).
55. McIver, L. et al. Characterisation of flavodoxin NADP + oxidoreductase and flavodoxin; key components of electron transfer in Escherichia coli. Eur. J. Biochem. 257, 577-585 (1998).
56. Sabbadin, F., Grogan, G. & Bruce, N. C. LICRED: a versatile drop-in vector for rapid generation of redox-self-sufficient cytochromes P450. Methods Mol. Biol. 987, 239-249, doi:10.1007/978-1-62703-321-3-20 (2013).
57. Hirakawa, H. & Nagamune, T. Use of Sulfolobus solfataricus PCNA subunit proteins to direct the assembly of multimeric enzyme complexes. Methods Mol. Biol. 978, 149-163, doi:10.1007/978-1-62703-293-3-11 (2013).
58. Jung, S. T., Lauchli, R. & Arnold, F. H. Cytochrome P450: taming a wild type enzyme. Curr. Opin. Biotechnol. 22, 809-817, doi:10.1016/j.copbio.2011.02.008 (2011).
59. Argos, P. An investigation of oligopeptides linking domains in protein tertiary structures and possible candidates for general gene fusion. J. Mol. Biol. 211, 943-958, doi:10.1016/0022-2836(90)90085-Z (1990).
60. George, R. A. & Heringa, J. An analysis of protein domain linkers: their classification and role in protein folding. Protein Eng. 15, 871-879 (2002).
61. Tanaka, T., Yokoyama, S. & Kuroda, Y. Improvement of domain linker prediction by incorporating loop-length-dependent characteristics. Biopolymers 84, 161-168, doi:10.1002/bip.20361 (2006).
62. Chichili, V. P. R., Kumar, V. & Sivaraman, J. Linkers in the structural biology of protein-protein interactions. Protein Sci. 22, 153-167, doi:10.1002/pro.2206 (2013).
63. Evers, T. H., van Dongen, E. M., Faesen, A. C., Meijer, E. W. & Merkx, M. Quantitative understanding of the energy transfer between fluorescent proteins connected via flexible peptide linkers. Biochemistry 45, 13183-13192, doi:10.1021/bi061288t (2006).
64. Arai, R., Wriggers, W., Nishikawa, Y., Nagamune, T. & Fujisawa, T. Conformations of variably linked chimeric proteins evaluated by synchrotron X-ray small-angle scattering. Proteins 57, 829-838, doi:10.1002/prot.20244 (2004).
65. Klein, J. S., Jiang, S., Galimidi, R. P., Keeffe, J. R. & Bjorkman, P. J. Design and characterization of structured protein linkers with differing flexibilities. Protein Eng. Des. Sel. 27, 325-330, doi:10.1093/protein/gzu043 (2014).
66. Hall, D. A. et al. Mapping the interactions between flavodoxin and its physiological partners flavodoxin reductase and cobalamindependent methionine synthase. Proc. Natl. Acad. Sci. USA. 98, 9521-9526 (2001).
67. Hlavica, P. Mechanistic basis of electron transfer to cytochromes p450 by natural redox partners and artificial donor constructs. Adv. Exp. Med. Biol. 851, 247-297, doi:10.1007/978-3-319-16009-2-10 (2015).
68. Rühlmann, A., Antovic, D., Müller, T. J. J. & Urlacher, V. B. Regioselective Hydroxylation of Stilbenes by Engineered Cytochrome P450 from Thermobifida fusca YX. Adv. Synth. Catal. 359, 984-994 (2017).
69. Bracco, P., Janssen, D. B. & Schallmey, A. Selective steroid oxyfunctionalisation by CYP154C5, a bacterial cytochrome P450. Microb. Cell Fact. 12, 95, doi:10.1186/1475-2859-12-95 (2013).
70. Jang, H. H. et al. Regioselective C-H hydroxylation of omeprazole sulfide by Bacillus megaterium CYP102A1 to produce a human metabolite. Biotechnol. Lett. 39, 105-112, doi:10.1007/s10529-016-2211-3 (2017).
71. Maurer, S. C. et al. Catalytic hydroxylation in biphasic systems using CYP102A1 mutants. Adv. Synth. Catal. 347, 1090-1098 (2005).
72. Dennig, A., Lülsdorf, N., Liu, H. & Schwaneberg, U. Regioselective o-hydroxylation of monosubstituted benzenes by P450 BM3. Angew. Chem. Int. Ed. Engl. 52, 8459-8462, doi:10.1002/anie.201303986 (2013).
73. Müller, C. A. et al. A whole cell biocatalyst for double oxidation of cyclooctane. J. Ind. Microbiol. Biotechnol. 43, 1641-1646, doi:10.1007/s10295-016-1844-5 (2016).
74. Fasan, R., Chen, M. M., Crook, N. C. & Arnold, F. H. Engineered alkane-hydroxylating cytochrome P450(BM3) exhibiting nativelike catalytic properties. Angew. Chem. Int. Ed. Engl. 46, 8414-8418 (2007).
75. Honda Malca, S., Girhard, M., Schuster, S., Durre, P. & Urlacher, V. B. Expression, purification and characterization of two Clostridium acetobutylicum flavodoxins: Potential electron transfer partners for CYP152A2. Biochim. Biophys. Acta 1814, 257-264, doi:10.1016/j.bbapap.2010.06.013 (2011).
76. Lisurek, M., Kang, M. J., Hartmann, R. W. & Bernhardt, R. Identification of monohydroxy progesterones produced by CYP106A2 using comparative HPLC and electrospray ionisation collision-induced dissociation mass spectrometry. Biochem. Biophys. Res. Commun. 319, 677-682 (2004).